Simon Read is the founder of Curie Therapeutics. Curie Therapeutics has raised $75M in total funding. Latest round: Series A. Based in Cambridge, Mass..
Simon Read is the Founder and Chief Executive Officer of Curie Therapeutics, a company developing precision radiopharmaceuticals for cancer care. He previously served as CSO of Ra Pharma and was an Entrepreneur in Residence at Atlas Venture. Read holds a Ph.D. and has experience in peptide discovery and development, and in building clinical-stage biotech companies.
Full founder directory · Investor directory · Company funding database · Fundraising library